Motzer RJ, Penkov K, Haanen JBAG, et al. JAVELIN Renal 101: A randomized, phase III study of avelumab + axitinib vs sunitinib as first-line treatment of advanced renal cell carcinoma (aRCC). ESMO 2018, abstract LBA6_PR.
Europese consensusaanbevelingen voor oligo-gemetastaseerd slokdarm-/maagcarcinoom
feb 2024 | Maag-darm-leveroncologie